A Study of Single and Multiple Doses of KW-6356 in Healthy Subjects

NCT03830528 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: KW-6356 Low Dose
DRUG: KW-6356 Middle Dose
DRUG: KW-6356 High Dose
DRUG: KW-6356 X Dose
DRUG: KW-6356 Y Dose
DRUG: Placebo

Sponsor

Kyowa Kirin Co., Ltd.